A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
Clinical trial NCT01463306 · COMPLETED
Trial details
- NCT number
- NCT01463306
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-21
- Primary completion
- 2019-08-22
- Enrollment
- 605
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.